Northeast Financial Consultants’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,073
| Closed | -$418K | – | 299 |
|
|
2023
Q1 | $418K | Hold |
2,073
| – | – | 0.03% | 212 |
|
|
2022
Q4 | $452K | Hold |
2,073
| – | – | 0.03% | 198 |
|
|
2022
Q3 | $408K | Buy |
2,073
+279
| +16% | +$54.9K | 0.03% | 218 |
|
|
2022
Q2 | $384K | Buy |
1,794
+312
| +21% | +$66.8K | 0.03% | 227 |
|
|
2022
Q1 | $421K | Buy |
1,482
+385
| +35% | +$109K | 0.02% | 250 |
|
|
2021
Q4 | $413K | Buy |
+1,097
| New | +$413K | 0.02% | 243 |
|